AWS for Industries
Tag: pharmaceuticals
Accelerating Drug Discovery with AWS HealthOmics and NVIDIA Blueprints
Figure 1 Discovering new life-changing therapies has never been more urgent, yet the drug discovery process remains a complex and time-consuming endeavor. To accelerate breakthroughs, leading biotech and biopharma companies are turning to Biological Foundation Models (BioFMs), a type of advanced generative AI models trained on biological data. We are excited to announce that NVIDIA’s […]
MSD Builds HawkAVI Platform on AWS to Reduce Product Reject Rates
Blog is guest authored by Nitin Kaul and Guglielmo Iozzia of Merck & Co., Inc. Improving the productivity of manufacturing operations is vital for pharmaceutical companies, so patients can get the critical medicines they need, faster. While patient safety has always been the highest priority, Merck & Co., Inc. (MSD), the leading global biopharmaceutical company, […]
AstraZeneca’s Drug Design Program Built using AWS wins Innovation Award
At the 20th anniversary of the Bio-IT World Conference, held in Boston, in May 2022, AstraZeneca received the BioIT World Innovative Practice Award for its novel Augmented Drug Design Platform, built on AWS. Biopharma R&D productivity and success rates have been an industry-wide challenge, with the drug discovery process often compared to finding a needle in […]